Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cipher Pharmaceuticals (CPHRF)
OTHER OTC:CPHRF
RESEARCH TOOLSreports
Cipher Pharmaceuticals (CPHRF) Stock Price & Analysis
15 Followers
CPHRF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.20 - $7.37
Previous Close$6.5
Volume3.90K
Average Volume (3M)22.32K
Market Cap
$154.92M
Enterprise Value$115.45M
Total Cash (Recent Filing)$39.83M
Total Debt (Recent Filing)$353.00K
Price to Earnings (P/E)7.9
Beta-0.38
Next Earnings
May 09, 2024EPS Estimate
$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.82
Shares Outstanding23,989,953
10 Day Avg. Volume10,969
30 Day Avg. Volume22,319
Standard Deviation0.17
R-Squared0.06
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)2.36
Price to Sales (P/S)7.37
Price to Cash Flow (P/CF)15.40
P/FCF Ratio16.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.46
Enterprise Value/Gross Profit6.75
Enterprise Value/Ebitda6.94
Forecast
1Y Price Target
$5.86Price Target Upside-5.94% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Cipher Pharmaceuticals News
PremiumCompany Announcements
Cipher Pharmaceuticals Posts Steady Growth in 2023
Options Prices
Currently, No data available
---
Ownership Overview
51.56% Insiders
0.95% Mutual Funds
0.84% Other Institutional Investors
46.65% Public Companies and
Individual Investors
CPHRF FAQ
What was Cipher Pharmaceuticals’s price range in the past 12 months?
Cipher Pharmaceuticals lowest stock price was $2.20 and its highest was $7.37 in the past 12 months.
What is Cipher Pharmaceuticals’s market cap?
Currently, no data Available
When is Cipher Pharmaceuticals’s upcoming earnings report date?
Cipher Pharmaceuticals’s upcoming earnings report date is May 09, 2024 which is in 13 days.
How were Cipher Pharmaceuticals’s earnings last quarter?
Cipher Pharmaceuticals released its earnings results on Mar 14, 2024. The company reported $0.3 earnings per share for the quarter, beating the consensus estimate of $0.095 by $0.205.
Is Cipher Pharmaceuticals overvalued?
According to Wall Street analysts Cipher Pharmaceuticals’s price is currently Overvalued.
Does Cipher Pharmaceuticals pay dividends?
Cipher Pharmaceuticals does not currently pay dividends.
What is Cipher Pharmaceuticals’s EPS estimate?
Cipher Pharmaceuticals’s EPS estimate is $0.1.
How many shares outstanding does Cipher Pharmaceuticals have?
Cipher Pharmaceuticals has 24,022,339 shares outstanding.
What happened to Cipher Pharmaceuticals’s price movement after its last earnings report?
Cipher Pharmaceuticals reported an EPS of $0.3 in its last earnings report, beating expectations of $0.095. Following the earnings report the stock price went up 13.283%.
Which hedge fund is a major shareholder of Cipher Pharmaceuticals?
Currently, no hedge funds are holding shares in CPHRF
---
Cipher Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
158.75%
12-Months-Change
Fundamentals
Return on Equity
28.19%
Trailing 12-Months
Asset Growth
16.61%
Trailing 12-Months
Company Description
Cipher Pharmaceuticals
Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. Its products include dermatology, hospital acute care, and out-licensed products. The company was founded in 2000 and is headquartered in Oakville, Canada.
---
CPHRF Earnings Call
Q4 2024
0:00 / 0:00
---
CPHRF Stock 12 Months Forecast
Average Price Target
$5.86
▼(-5.94% Downside)
Technical Analysis
---